Advertisement

Carcinosarcoma of the Breast: An Aggressive Subtype of Metaplastic Cancer. Report of a Rare Case in a Young BRCA-1 Mutated Woman

Published:August 29, 2016DOI:https://doi.org/10.1016/j.clbc.2016.08.002
      Carcinosarcoma of the breast (BCS), a subtype of metaplastic breast cancer, is an extremely rare and clinically aggressive tumor containing carcinomatous and nonepithelial components of mesenchymal origin with a clear-cut boundary between them.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Breast Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Weigelt B.
        • Kreike B.
        • Reis-Filho J.S.
        Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis.
        Breast Cancer Res Treat. 2009; 117: 273-280
        • Suspitsin E.N.
        • Sokolenko A.P.
        • Voskresenskiy D.A.
        • et al.
        Mixed epithelial/mesenchymal metaplastic carcinoma (carcinosarcoma) of the breast in BRCA1 carrier.
        Breast Cancer. 2011; 18: 137-140
        • Xian Z.
        • Hong S.
        • Ying Y.
        Intraductal carcinoma and carcinosarcoma with bone metastases presenting in one breast: a case report.
        Oncol Lett. 2014; 8: 2678-2680
        • Schwartz T.L.
        • Mogal H.
        • Papageorgiou C.
        • Veerapong J.
        • Hsueh E.
        Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies.
        Exp Hematol Oncol. 2013; 2: 31
        • Breuer A.
        • Kandel M.
        • Fisseler-Eckhoff A.
        • et al.
        BRCA1 germline mutation in a woman with metaplastic squamous cell breast cancer.
        Onkologie. 2007; 30: 316-318
        • Santarosa M.
        • Maestro R.
        BRACking news on triple-negative/basal-like breast cancers: how BRCA1 deficiency may result in the development of a selective tumor subtype.
        Cancer Metastasis Rev. 2012; 31: 131-142
        • Stefaniuk C.M.
        • Jones T.
        Double feature: carcinoma and sarcoma present in a single breast tumour.
        Case Rep Oncol Med. 2012; 2012: 232851
        • Tian W.
        • Dong X.
        Diagnosis and management of multiple carcinosarcoma of the breast in a young Chinese patient.
        Breast Care. 2012; 7: 147-149
        • Ilhan E.
        • Vardar E.
        • Ozkok G.
        • et al.
        A rare tumour of the breast: carcinosarcoma.
        J Clin Med Res. 2010; 2: 96-98
        • Esses K.M.
        • Hagmaier R.M.
        • Blanchard S.A.
        • Lazarchick J.J.
        • Riker A.I.
        Carcinosarcoma of the breast: two case reports and review of the literature.
        Cases J. 2009; 2: 15
        • Yakan S.
        • Sarı E.
        • Erkan N.
        • et al.
        Breast carcinosarcomas.
        J Breast Health. 2014; 10: 161-165
        • Yu K.
        • Shu K.
        • Quingchang L.
        • Xinyu Z.
        Mixed epithelial and mesechymal metaplastic carcinoma (carcinosarcoma) of the breast: a case report.
        Eur J Med Res. 2014; 19: 14
        • Terando A.M.
        • Agnese D.
        • Holmes D.R.
        Treatment and prognosis of rare breast cancers.
        Ann Surg Oncol. 2015; 22: 3225-3229
        • Cakir A.
        • Gönül I.I.
        • Uluoğlu O.
        Metaplastic breast carcinomas and their relationship with basal-like phenotype.
        Turk Patoloji Derg. 2012; 28: 134-141
        • Heerma van Voss M.R.
        • van der Groep P.
        • Bart J.
        • van der Wall E.
        • van Diest P.J.
        Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.
        Cell Oncol. 2011; 34: 3-10
        • Park J.M.
        • Han B.K.
        • Moon W.K.
        • Choe Y.H.
        • Ahn S.H.
        • Gong G.
        Metaplastic carcinoma of the breast: mammographic and sonographic findings.
        J Clin Ultrasound. 2000; 28: 179-186
        • Velasco M.
        • Santamaria G.
        • Ganau S.
        • Farrus B.
        • Zanon G.
        • Romagosa C.
        MRI of metaplastic carcinoma of the breast.
        Am J Roentgenol. 2005; 184: 1274-1278
        • Villalon-Lopez J.S.
        • Souto del Bosque R.
        • Alanso Briones M.Y.
        • Truillo de Anda A.P.
        Carcinosarcoma of the breast: a rare entity with fatal prognosis. One case report.
        Cir Cir. 2013; 81: 328-332
        • Hennessy B.T.
        • Giordano S.
        • Broglio K.
        • et al.
        Biphasic metaplastic sarcomatoid carcinoma of the breast.
        Ann Oncol. 2006; 17: 605-613
        • Park H.S.
        • Park S.
        • Kim J.H.
        • et al.
        Clinicopathologic features and outcomes of metaplastic breast carcinoma: comparison with invasive ductal carcinoma of the breast.
        Yonsei Med J. 2010; 51: 864-869
        • Pezzi C.M.
        • Patel-Parekh L.
        • Cole K.
        • Franco J.
        • Klimberg S.
        • Bland K.
        Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Database.
        Ann Surg Oncol. 2006; 14: 166-173
        • Rayson D.
        • Adjei A.A.
        • Suman V.J.
        • Wold L.E.
        • Ingle J.N.
        Metaplastic breast cancer: prognosis and response to systemic therapy.
        Ann Oncol. 1999; 10: 413-419
        • Wargotz E.S.
        • Norris H.J.
        Metaplastic carcinomas of the breast. III. Carcinosarcoma.
        Cancer. 1989; 64: 1490-1499
        • Kim S.H.
        • Chung H.C.
        • Jeong J.
        • Kim J.H.
        • Rha S.Y.
        • Ahn J.B.
        A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin and taxane-based neoadjuvant chemotherapy.
        Cancer Res Treat. 2007; 39: 134-137
        • Chen I.C.
        • Lin C.H.
        • Huang C.S.
        • et al.
        Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era.
        Breast Cancer Res Treat. 2011; 130: 345-351
        • Gutman H.
        • Pollok R.E.
        • Janjan N.A.
        Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast.
        J Am Coll Surg. 1995; 180: 193-199
        • Cardoso F.
        • Bedard P.L.
        • Winer E.P.
        • et al.
        International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
        J Natl Cancer Inst. 2009; 101: 1174-1181
        • Tseng W.H.
        • Martinez S.R.
        Metaplastic breast cancer: to radiate or not to radiate?.
        Ann Surg Oncol. 2001; 18: 94-103
        • Nelson R.A.
        • Guye M.L.
        • Luu T.
        • Lai L.L.
        Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis.
        Ann Surg Oncol. 2015; 22: 24-31